William Blair Investment Management LLC cut its holdings in shares of ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 18.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 140,909 shares of the medical instruments supplier’s stock after selling 31,272 shares during the quarter. William Blair Investment Management LLC’s holdings in ICU Medical were worth $22,617,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Gagnon Securities LLC increased its stake in shares of ICU Medical by 0.8% in the third quarter. Gagnon Securities LLC now owns 29,630 shares of the medical instruments supplier’s stock worth $4,756,000 after purchasing an additional 230 shares in the last quarter. Maryland State Retirement & Pension System lifted its stake in shares of ICU Medical by 52.7% during the 3rd quarter. Maryland State Retirement & Pension System now owns 5,549 shares of the medical instruments supplier’s stock valued at $891,000 after buying an additional 1,914 shares in the last quarter. Jefferies Financial Group Inc. purchased a new stake in shares of ICU Medical during the 3rd quarter valued at approximately $987,000. Illinois Municipal Retirement Fund lifted its stake in shares of ICU Medical by 9.2% during the 3rd quarter. Illinois Municipal Retirement Fund now owns 13,788 shares of the medical instruments supplier’s stock valued at $2,213,000 after buying an additional 1,162 shares in the last quarter. Finally, Lido Advisors LLC boosted its holdings in ICU Medical by 15.4% in the 3rd quarter. Lido Advisors LLC now owns 3,707 shares of the medical instruments supplier’s stock worth $595,000 after buying an additional 494 shares during the period. Institutional investors own 96.10% of the company’s stock.
Analysts Set New Price Targets
A number of research analysts recently weighed in on ICUI shares. Weiss Ratings upgraded shares of ICU Medical from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Zacks Research downgraded ICU Medical from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 28th. Wall Street Zen raised ICU Medical from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Needham & Company LLC lifted their price target on ICU Medical from $165.00 to $187.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Finally, BTIG Research lifted their price target on ICU Medical from $170.00 to $200.00 and gave the company a “buy” rating in a research report on Friday, August 7th. Two research analysts have rated the stock with a Strong Buy rating, four have issued a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $195.20.
Insider Activity at ICU Medical
In other news, VP Virginia Sanzone sold 4,856 shares of the business’s stock in a transaction on Thursday, September 3rd. The shares were sold at an average price of $168.69, for a total transaction of $819,158.64. Following the completion of the transaction, the vice president directly owned 14,604 shares in the company, valued at $2,463,548.76. The trade was a 24.95% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Elisha W. Finney sold 1,700 shares of the business’s stock in a transaction on Friday, November 13th. The shares were sold at an average price of $179.00, for a total transaction of $304,300.00. Following the transaction, the director owned 4,871 shares of the company’s stock, valued at $871,909. This trade represents a 25.87% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 6,621 shares of company stock worth $1,135,094 over the last quarter. Corporate insiders own 2.10% of the company’s stock.
ICU Medical Price Performance
Shares of ICU Medical stock traded up $1.97 on Friday, reaching $179.27. The stock had a trading volume of 195,454 shares, compared to its average volume of 278,884. ICU Medical, Inc. has a 1 year low of $113.37 and a 1 year high of $192.85. The company has a market cap of $4.48 billion, a P/E ratio of 75.01, a price-to-earnings-growth ratio of 2.23 and a beta of 0.88. The company has a current ratio of 2.37, a quick ratio of 1.19 and a debt-to-equity ratio of 0.52. The business’s 50 day moving average is $163.72 and its two-hundred day moving average is $149.91.
ICU Medical (NASDAQ:ICUI – Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The medical instruments supplier reported $2.44 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.30. The company had revenue of $556.22 million during the quarter, compared to analyst estimates of $552.03 million. ICU Medical had a net margin of 2.76% and a return on equity of 8.40%. ICU Medical’s revenue was up 4.4% compared to the same quarter last year. During the same period last year, the business earned $2.03 earnings per share. As a group, research analysts anticipate that ICU Medical, Inc. will post 7.22 EPS for the current year.
ICU Medical Profile
ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.
Read More
- Five stocks we like better than ICU Medical
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
Want to see what other hedge funds are holding ICUI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ICU Medical, Inc. (NASDAQ:ICUI – Free Report).
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
